Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected

por Todorova, Antoniya, Jenner, Peter, Ray Chaudhuri, K
Publicado 2014

Editorial: Movement Disorders and Sleep – Underlying Mechanisms, Clinical Aspects and Treatment

por Falup-Pecurariu, Cristian, Titova, Nataliya, Ray Chaudhuri, K.
Publicado 2019

‘Levodopa Phobia’: a review of a not uncommon and consequential phenomenon

por Titova, Nataliya, Levin, Oleg, Katunina, Elena, Ray Chaudhuri, K.
Publicado 2018

Implications of dopaminergic medication withdrawal in Parkinson’s disease

por Koschel, J., Ray Chaudhuri, K., Tönges, L., Thiel, M., Raeder, V., Jost, W. H.
Publicado 2021

Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease

por Tall, P., Qamar, M. A., Batzu, L., Leta, V., Falup-Pecurariu, C., Ray Chaudhuri, K.
Publicado 2023

Burden of non‐motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa‐carbidopa intestinal gel

por Ray Chaudhuri, K., Antonini, A., Robieson, W. Z., Sanchez‐Soliño, O., Bergmann, L., Poewe, W.
Publicado 2018

Grey-matter correlates of empathy in 4-Repeat Tauopathies

por Tafuri, Benedetta, Urso, Daniele, Nigro, Salvatore, Macchitella, Luigi, De Blasi, Roberto, Ray Chaudhuri, K., Logroscino, Giancarlo
Publicado 2023

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future

por Ray Chaudhuri, K, Qamar, Mubasher A, Rajah, Thadshani, Loehrer, Philipp, Sauerbier, Anna, Odin, Per, Jenner, Peter
Publicado 2016

Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease

por Urso, Daniele, Leta, Valentina, Batzu, Lucia, Yousaf, Tayyabah, Farrell, Chloe, van Wamelen, Daniel J., Ray Chaudhuri, K.
Publicado 2021

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now

por Boura, Iro, Qamar, Mubasher A., Daddoveri, Francesco, Leta, Valentina, Poplawska-Domaszewicz, Karolina, Falup-Pecurariu, Cristian, Ray Chaudhuri, K.
Publicado 2023

Magnetic Resonance Parkinsonism Index Is Associated with REM Sleep Behavior Disorder in Parkinson’s Disease

por Urso, Daniele, Nigro, Salvatore, Tafuri, Benedetta, Gnoni, Valentina, Filardi, Marco, De Blasi, Roberto, Ray Chaudhuri, K., Logroscino, Giancarlo
Publicado 2022

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

por Seppi, Klaus, Ray Chaudhuri, K., Coelho, Miguel, Fox, Susan H., Katzenschlager, Regina, Perez Lloret, Santiago, Weintraub, Daniel, Sampaio, Cristina
Publicado 2019

Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels

por Voon, Valerie, Rizos, Alexandra, Chakravartty, Riddhika, Mulholland, Nicola, Robinson, Stephanie, Howell, Nicholas A, Harrison, Neil, Vivian, Gill, Ray Chaudhuri, K
Publicado 2014

Effects of safinamide on pain in patients with fluctuating Parkinson's disease

por Grigoriou, Sotirios, Martínez‐Martín, Pablo, Ray Chaudhuri, K., Rukavina, Katarina, Leta, Valentina, Hausbrand, Denise, Falkenburger, Björn, Odin, Per, Reichmann, Heinz
Publicado 2021

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus

por Stocchi, Fabrizio, Antonini, Angelo, Berg, Daniela, Bergmans, Bruno, Jost, Wolfgang, Katzenschlager, Regina, Kulisevsky, Jaime, Odin, Per, Valldeoriola, Francesc, Ray Chaudhuri, K.
Publicado 2022

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone

por Leta, Valentina, van Wamelen, Daniel J., Aureli, Federico, Metta, Vinod, Trivedi, Dhaval, Cortelli, Pietro, Rodriguez-Blazquez, Carmen, Rizos, Alexandra, Ray Chaudhuri, K.
Publicado 2023

Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease

por Urso, Daniele, van Wamelen, Daniel J., Batzu, Lucia, Leta, Valentina, Staunton, Juliet, Pineda-Pardo, José A., Logroscino, Giancarlo, Sharma, Jagdish, Ray Chaudhuri, K.
Publicado 2022

Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients: an European multicentre survey

por Rizos, A., Sauerbier, A., Falup-Pecurariu, C., Odin, P., Antonini, A., Martinez-Martin, P., Kessel, B., Henriksen, T., Silverdale, M., Durner, G., Ray Chaudhuri, K.
Publicado 2020

Viruses, parkinsonism and Parkinson’s disease: the past, present and future

por Leta, Valentina, Urso, Daniele, Batzu, Lucia, Lau, Yue Hui, Mathew, Donna, Boura, Iro, Raeder, Vanessa, Falup-Pecurariu, Cristian, van Wamelen, Daniel, Ray Chaudhuri, K.
Publicado 2022

Dysregulation of epithelial ion transport and neurochemical changes in the colon of a parkinsonian primate

por Coletto, Erika, Tough, Iain R., Pritchard, Sara, Hikima, Atsuko, Jackson, Michael J., Jenner, Peter, Ray Chaudhuri, K., Cox, Helen M., Iravani, Mahmoud M., Rose, Sarah
Publicado 2021